Raymond James Financial Inc Scynexis Inc Transaction History
Raymond James Financial Inc
- $299 Billion
- Q3 2025
A detailed history of Raymond James Financial Inc transactions in Scynexis Inc stock. As of the latest transaction made, Raymond James Financial Inc holds 21,584 shares of SCYX stock, worth $12,734. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,584
Previous 21,584
-0.0%
Holding current value
$12,734
Previous $14,000
21.43%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SCYX
# of Institutions
47Shares Held
12.5MCall Options Held
0Put Options Held
0-
Avidity Partners Management LP Dallas, TX3.35MShares$1.98 Million1.43% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$1.32 Million0.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$1.04 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.58MShares$934,1750.0% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC556KShares$327,7770.7% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $19.3M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...